Skip to main content

What are the Viscosupplementation Market Key Insights and COVID-19 Business Impact?

       

The abrupt occurrence of the COVID-19 pandemic has imposed a positive impact on the global viscosupplementation market growth in 2020. Growing demand for viscosupplementation for treating osteoarthritis patients is boosting the growth of the market. Analysts have anticipated that market will observe incessant growth after the end of the COVID-19 disaster.

Scenario of the Market before and after COVID-19 Pandemic:

Research Dive has added a new report on the global viscosupplementation market to its repository. The report reveals the impact of COVID-19 pandemic on the growth of the market. Before the rise of the pandemic, the market was estimated to grow at a CAGR of 10.2% from 2019 to 2026. Nevertheless, the unexpected outburst of COVID-19 pandemic has boosted the growth of the market. Market professionals have projected that the market will grow at a CAGR of 10.6% and garner $5,866.2 million, after the end of COVID-19 pandemic. This is mainly due to the rising demand for viscosupplementation due to rising cases of osteoarthritis in elderly population.

Present Scenario of the Market during COVID-19 Crisis:

Before the outbreak of the pandemic, the global viscosupplementation market was expected to hit $2,845.3 million in 2020. However, in the current circumstances, i.e. in 2020, the market size has stretched up to $2,903.3 million. The rise in the growth of the market is chiefly owing to the mounting demand for viscosupplementation for treating osteoarthritis patients. Amidst this crisis period, a significant rise in the number of osteoarthritis cases particularly in the elderly population has been witnessed. As per a publication by the United Nations (UN), by 2050, about 130 million people are likely to suffer from osteoarthritis worldwide.

Top Players of the Market:

Some of the major players active in the viscosupplementation market are Anika Therapeutics, Inc., OrthogenRx, Bioventus., Fidia Farmaceutici S.p.A., Aptissen, ecnofarma S.A., Zimmer Biomet, TRB Chemedica International SA, Stellar Pharmaceuticals Inc., and Dr. Reddy’s Laboratories Ltd. Additionally, the report outlines the business overview including financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis of all key players of the market.

As a response to COVID-19 catastrophe, market players are devising numerous business strategies, for instance, strategic agreements, technological inventions, and collaborations to survive their business. For example, OrthogenRx, Inc., a medical device manufacturing company has announced the initialization of patient programs called TriVisc Direct Purchase Program and TriVisc Patient Assistance Program, in May 2020.

Outlook of the Market Post COVID-19 Pandemic:

As per market researchers, the global viscosupplementation market is expected to continue to grow at a significant growth rate after the end of the COVID-19 crisis. This is mainly due to an upsurge in the number of sports related joint injuries owing to growing adoption of sports in upcoming years. Additionally, growing technological advances and increasing investments in the viscosupplementation technology are estimated to unlock rewarding opportunities and boost the growth of the global viscosupplementation market after the end of the COVID-19 pandemic.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Comments

Popular posts from this blog

Growth Outlook: Healthcare Gamification Market Expand their Businesses with New Investments

   Download FREE Sample The healthcare gamification market share is predicted to grow at a CAGR of 11.9% by generating a revenue of $47,281.5 Million by 2026. Gamification includes applying the techniques used in game, mechanics of game, and game style in non-gaming applications to engage the audience and make the dull task into more fun and engaging. Basically it is an application of elements in video games, which helps to solve the everyday problem and enables the user to change the behavior, develop skills and enable innovation in health care. The  goal of the gamification  is to change the behavior of the patient. The increase in the wearables and health & wellness app with gamification is the strong sign that the people are liking it. The increase in the usage of digitalization and the technology adoption are expected to drive the healthcare gamification market. Many companies are using the digital platform for the people to check their health data. For...

COVID-19 Impact: What Challenges Hand Sanitizer Market May See In Next 5 Years?

   Inquire Here Before Purchase and Get FREE Sample The communal transmission of COVID-19 has created a significant impact on the hand sanitizer market growth, throughout the projected timeframe. The growth of the global hand sanitizer market is mainly driven by the rising concern about personal safety among the customers. Furthermore, the extensively growing prevalence of viral disorders globally is also creating a huge demand for hand sanitizers, in the review period. Though the businesses across the globe have strictly imposed lockdown in order to reduce the impact of the pandemic spread, the  global hand sanitizer industry  has shown exponential growth. The ventures involved with hand sanitizer production are adopting numerous strategic steps like product & technology advancements, strategic tie-ups. For example, in June 2020, Procter & Gamble (P&G), has made an announcement to launch of newly invented ‘safeguard sanitizer’. In addition, the enterpris...

What are the Left Atrial Appendage Closure Devices Market Key Insights and COVID-19 Business Impact?

   Download FREE Sample Connect with Analyst The COVID-19 outbreak has significantly affected the global left atrial appendage closure devices market. As per American Heart Association, people having high blood pressure, heart valve disease and congenital heart diseases are expected to develop severe coronavirus symptoms. Also, this virus can generate heart strokes through weakening of muscles of the heart. These fators will boost the demand for left atrial appendage closure divices and surge the market growth during the pandemic. Furthermore, the leading manufactures in the global market are adopting various strategies such as product innovations and partnerships to increase their market share in the overall industry. For example, in July 2020, Boston Scientific Corporation announced that the “Watchman FLX left atrial appendage closure device” has been approved by U.S. Food and Drug Administration, which is used to minimize the threat of heart stroke in patients. The stroke r...